BofA Securities analyst Travis Steed maintains $Intuitive Surgical (ISRG.US)$ with a buy rating, and maintains the target price at $550.
According to TipRanks data, the analyst has a success rate of 65.1% and a total average return of 7.3% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Intuitive Surgical (ISRG.US)$'s main analysts recently are as follows:
Intuitive Surgical's Q3 earnings surpassed expectations, signaling a robust quarter bolstered by the placement of Da Vinci 5 systems, significant procedure volume growth, and consistent margin management. The company has revised its FY24 procedure volume growth forecast to a range of 16%-17%, with the adjusted lower end accounting for potential declines in bariatric procedures and persisting challenges in Asia, including ongoing physician strikes in Korea, while the upper end presumes stability in bariatric procedures and no escalation of headwinds in Korea and China.
The expectation is that the Street may be anticipating a significant revenue outperformance for FY25. This is following the company's quarterly report, after which projections for FY25 earnings per share were moderately increased by approximately 3%.
Intuitive Surgical's third-quarter performance was robust, surpassing projections in key areas such as DV5 placements and procedure growth. Post-launch growth momentum is significant, following the U.S. da Vinci 5 approval, with early uptake surpassing that of the fourth-generation system. These strong growth indicators hint at a potential uptick in acceleration by 2025.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美银证券分析师Travis Steed维持$直觉外科公司 (ISRG.US)$买入评级，维持目标价550美元。
根据TipRanks数据显示，该分析师近一年总胜率为65.1%，总平均回报率为7.3%。
此外，综合报道，$直觉外科公司 (ISRG.US)$近期主要分析师观点如下：
直觉外科公司的第三季度收入超出预期，表明由达芬奇5系统放置、重大程序成交量增长和一贯边际管理支撑的强劲季度。公司已将FY24程序成交量增长预测修订为16%-17%的区间，调整后的下限考虑了减少减肥手术程序和亚洲持续挑战的可能性，包括韩国持续发生的医生罢工，而上限则假定减肥手术的稳定和韩国和中国风险不升级。
外界预期街头可能在FY25期间预计营收将大幅超出预期。这是在公司季度报告之后，其后FY25每股收益预测略有增加约3%。
直觉外科公司的第三季度表现强劲，超越了关键领域的预期，如DV5放置和程序增长。推出后的增长势头显著，在美国达芬奇5获批后，早期接受超过第四代系统。这些强劲增长的因子暗示2025年可能会出现加速增长。
提示:
TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。
TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。
分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。
总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。
